Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-10-24

Clinical Trial Update: Cardiovascular Biomarkers and Quetiapine in Depression and Anxiety Patients [Phase 4]

View source ↗

Summary

A Phase 4 study evaluated cardiovascular biomarkers in patients with depression and anxiety treated with quetiapine; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Quetiapine (Seroquel) (quetiapine)

Snippet

Sponsor: Loyola University | Conditions: Depression, Anxiety | Phase 4 | Status: COMPLETED | Results posted: 2016-10-24